Bill > HR3092

This bill aims to establish new requirements for electrodiagnostic services (specifically nerve conduction studies and needle electromyography tests) under Medicare, focusing on improving patient care and reducing potential fraud. The legislation mandates that these services can only be performed at "qualified facilities" accredited by organizations specified by the Secretary of Health and Human Services, with implementation occurring 3-4 years after enactment. Qualified facilities must meet stringent requirements, including maintaining a quality assurance program, using advanced diagnostic equipment, ensuring practitioners have specific training (at least 3 months in a accredited residency or fellowship program), and interpreting test results on-site at the time of the procedure. The bill also establishes a National Electrodiagnostic Services Advisory Committee composed of 9-11 non-government healthcare professionals who will provide recommendations on service requirements, regulations, and accreditation organizations. The committee's key priorities include reducing unnecessary treatments, improving diagnostic reliability, addressing potential fraud, and enhancing overall patient care quality. Importantly, the bill does not apply to interoperative neuromonitoring services, providing a specific exemption for that type of diagnostic procedure.